🇺🇸 FDA
Patent

US 7388074

Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof

granted A61KA61K38/00

Quick answer

US patent 7388074 (Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/00